GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Receipts from Customers

BerGenBio ASA (OSL:BGBIO) Receipts from Customers


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.


BerGenBio ASA Business Description

Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.